Investors

Stock price graph
     

BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.

View all »   RSSRecent Releases

Mar 31, 2015
BG Medicine Submits 510(k) to FDA for Additional Indication for the BGM Galectin-3(R) Test

Mar 31, 2015
BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results